AllNEB

FDA 510(k) K242354 · Enchant Tek Co. , Ltd.

Substantially Equivalent

510(k) numberK242354

Submission

Device name
AllNEB
Applicant
Enchant Tek Co. , Ltd.
Yilan County, TW
Received
August 8, 2024
Decision date
April 29, 2025
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
CAF – Nebulizer (Direct Patient Interface)
Device class
Class II (moderate risk)
Regulation
21 CFR 868.5630
Specialty
Anesthesiology

Other 510(k)s with product code CAF

510(k)DeviceApplicantDecision
K260270FindAir ONE for pMDI (FAO-MDI-V12-GRE-001)CAF · Traditional FindAir Sp. z o.o.06/02/2026SE
K251572eRapid with eTrack SystemCAF · Traditional Pari Respiratory Equipment, Inc.12/19/2025SE
K251659Mesh Nebulizer (H6)CAF · Traditional Qingdao Future Medical Technology Co., Ltd.11/14/2025SE
K244035Portable mesh nebulizer (JM821)CAF · Traditional Shenzhen Jermei Medical Device Technology Co.…09/19/2025SE
K243468Compressor Nebulizer (NB-1100); Compressor Nebulizer (NB-1101); Compressor Nebulizer…CAF · Traditional Joytech Healthcare Co. , Ltd.07/02/2025SE
K250022HeroTracker SenseCAF · Traditional Voluntis06/30/2025SE
K250583AdheResp Smart Breath-actuated Mesh NebulizerCAF · Traditional Hcmed Innovations Co., Ltd.06/20/2025SE
K233553MiniSpacer® 1024, 1025, 1543 and 1024A, 1025A, 1543A Dual Spray MDI AdapterCAF · Special Thayer Medical Corporation06/18/2024SE
K232507Aerogen®Solo Nebulizer SystemCAF · Traditional Aerogen, Ltd.05/10/2024SE
K232523Sodium Chloride Inhalation Solution, USP 0.9%, 3% & 7%CAF · Traditional Mankind Pharma Limited04/10/2024SE

More from Mankind Pharma Limited

510(k)DeviceDecision
K233855AllPEPBWF · Traditional 02/02/2024SE

Questions and answers

When was AllNEB cleared by the FDA?

AllNEB (K242354) received a 510(k) decision of Substantially Equivalent on April 29, 2025, 264 days after the submission was received.

What is the product code of K242354?

The FDA product code is CAF – Nebulizer (Direct Patient Interface), a Class II (moderate risk) device regulated under 21 CFR 868.5630.